Pathstone Holdings’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.3M | Sell |
280,159
-59,969
| -18% | -$4.14M | 0.08% | 175 |
|
|
2025
Q1 | $23.7M | Buy |
340,128
+65,227
| +24% | +$4.55M | 0.1% | 144 |
|
|
2024
Q4 | $23.6M | Sell |
274,901
-15,328
| -5% | -$1.32M | 0.1% | 133 |
|
|
2024
Q3 | $34.6M | Buy |
290,229
+734
| +0.3% | +$87.4K | 0.15% | 100 |
|
|
2024
Q2 | $41.3M | Buy |
289,495
+12,207
| +4% | +$1.74M | 0.19% | 85 |
|
|
2024
Q1 | $35.6M | Buy |
277,288
+122,229
| +79% | +$15.7M | 0.17% | 90 |
|
|
2023
Q4 | $16.1M | Buy |
+155,059
| New | +$16.1M | 0.09% | 168 |
|